Stem cell therapy: medical advance or moral challenge?

被引:0
|
作者
Lachmann, PJ [1 ]
机构
[1] Ctr Vet Sci, Microbial Immunol Grp, Cambridge CB3 0ES, England
关键词
stem cells; disease; moral;
D O I
10.1016/S1631-0691(02)01526-3
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
My professional lifetime has seen progress in the biomedical sciences that beggars belief. This has lead to astonishing advances in the ability to prevent and treat disease and, in the developed world at least, people live longer and healthier lives than ever before. Paradoxically, this has gone hand in hand with the growth of a vocal and influential anti-science lobby that not only rejects much modern science-but is also deeply suspicious of new medical interventions. The prospect of cell therapy in the near or middle future is their current target especially where the use of embryonic stem cells or of cell nuclear transfer techniques is concerned. The prospect of cell therapy is welcomed with enthusiasm by patients with genetic and degenerative diseases who hope to benefit from them. On the other hand the whole idea is regarded as repugnant by the anti-science lobby. While some of this opposition is essentially luddite in nature, there are some more persuasive arguments raised particularly to any research than uses embryonic or foetal materials. These arguments will be examined critically. The moral problems of denying the sick the hope of effective treatments have to be weighed against those seen in the development of such treatments. (This article is closely based on an already published paper. P. Lachmann, Stem cell research: why is it regarded as a threat? An investigation of the economic and ethical arguments made against research with human embryonic stem cells. EMBO Rep. 2 (3) (2001) 165-168).
引用
收藏
页码:1049 / 1051
页数:3
相关论文
共 50 条
  • [21] The ethical challenge of stem cell research
    Roche, PA
    Grodin, MA
    WOMENS HEALTH ISSUES, 2000, 10 (03) : 136 - 139
  • [22] Human embryonic stem-cell therapy (Exploring moral and ethical public policy issues)
    Shannon, TA
    THEOLOGICAL STUDIES, 2001, 62 (04) : 811 - 824
  • [23] Moral obligations in conducting stem cell-based therapy trials for autism spectrum disorder
    Yeo-Teh, Nicole Shu Ling
    Tang, Bor Luen
    JOURNAL OF MEDICAL ETHICS, 2022, 48 (05) : 343 - 348
  • [24] Stem cell and cell therapy
    Radbruch, A.
    Burmester, G. -R.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (03): : 195 - 195
  • [25] Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy
    Miceli, Vitale
    WORLD JOURNAL OF STEM CELLS, 2024, 16 (01):
  • [26] Advance of Stem Cell Treatment for Traumatic Brain Injury
    Zhou, Yunxiang
    Shao, Anwen
    Xu, Weilin
    Wu, Haijian
    Deng, Yongchuan
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [27] Integrating the Teaching and Assessment of Moral Reasoning into Undergraduate Medical Education to Advance Health Equity
    Chachad, Nisha
    Levy, Arkene
    Kenon, Katlynn
    Nash, Rachel
    Carter, Stefanie
    Padilla, Maria
    Mitchell-Williams, Jocelyn
    Rajput, Vijay
    MEDICAL SCIENCE EDUCATOR, 2024, 34 (03) : 653 - 659
  • [28] The Moral Bindingness of Advance Directives
    Vergallo, Gianluca Montanari
    CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2023, 32 (03) : 447 - 449
  • [29] Advance in metabolism and target therapy in breast cancer stem cells
    Gao, Xu
    Dong, Qiong-Zhu
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (11): : 1295 - 1306
  • [30] Medical Nutrition Therapy Provided to Adult Hematopoietic Stem Cell Transplantation Patients
    Habschmidt, Mary G.
    Bacon, Cheryl A.
    Gregoire, Mary B.
    Rasmussen, Heather E.
    NUTRITION IN CLINICAL PRACTICE, 2012, 27 (05) : 655 - 660